Varex Imaging Corp (VREX) Stock Price & Analysis
Varex Imaging Corp (VREX) rose 0.03% to USD 18.52 as of September 8, 2026 at 17:16 UTC, according to Nexqual real-time market data.
VREX last closed at USD 18.52; the session ranged USD 18.51–18.53 on volume of 210,523 shares. Market capitalization is —, with a 52-week range of USD 9.09–18.63 (NMS). Source: Nexqual, September 8, 2026 at 17:16 UTC.
Key Statistics (as of September 8, 2026 at 17:16 UTC)
| Price | USD 18.52 |
|---|---|
| Change | ▲ 0.03% (up) |
| Previous Close | USD 18.52 |
| Open | USD 18.52 |
| Day Range | USD 18.51 – 18.53 |
| 52-Week Range | USD 9.09 – 18.63 |
| Volume | 210,523 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (VREX)
Nexqual's technical model rates VREX "BUY" based on 5 bullish and 1 bearish signals across 127 daily candles, as of September 8, 2026 at 17:16 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 92.25 (overbought) |
| vs SMA50 | Above (USD 14.16) |
| MACD | 1.24 (positive) |
From Varex Imaging Corp's Latest SEC 10-K Filing (filed 2025-11-18)
Key Strengths & Strategy (as disclosed to the SEC)
- Our manufacturing operations for medical devices, and those of our third-party manufacturers, are required to comply with the FDA's Quality System Regulation ("QSR"), which addresses a company's responsibility for product design, testing, and manufacturing quality assurance, and the maintenance of records and documentation.
- As a participant in the healthcare industry, we are also subject to extensive laws and regulations protecting the privacy and integrity of patient medical information that we receive, including the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), new state privacy laws, "fraud and abuse" laws and regulations, including physician self-referral prohibitions, and false claims laws.
- As of October 3, 2025, we own approximately 240 patents issued in the United States, approximately 420 patents issued throughout the rest of the world and have approximately 210 patent applications pending with various patent agencies worldwide.
- Shubham (Sam) joined Varex from SiFive, Inc., a leading provider of hardware and software solutions for developing RISC-V based processors and semiconductor chips, where he served as CFO.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LIVN | LivaNova PLC | USD 80.99 | ▼ 0.26% |
| KIDS | OrthoPediatrics Corp. | USD 22 | ▼ 2.63% |
| MLAB | Mesa Laboratories, Inc. | USD 125.4 | ▼ 2.44% |
| OFIX | Orthofix Medical Inc. | USD 9.17 | ▼ 1.56% |
| NRC | NRC Health | USD 21.18 | ▼ 0.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:16 UTC. This page is informational and not investment advice.